Menu Back to Latin-America-Regulatory-Conference


Join global regulators, industry, and academia to engage in a series of strategic discussions on current regulatory landscape, globalization, and harmonization initiatives in Latin America.

DIA brings you a symposium with interactive dynamics, where you will be engaged in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives in Latin America.

Join us to discuss multi-regional cooperation, global harmonization, and best practices related to Latin America’s regulatory landscape. Sessions will highlight regulatory approaches and good practices to ensure reliance in Latin American and strategic initiatives to improve collaboration and cooperation.

DIA can provide a letter to confirm your onsite participation as long as you have:
A) already registered for this conference and
B) paid the registration for this conference.

To request a confirmation letter please send an email to

*The primary language is English, however simultaneous interpretation in English and Portuguese will be available during this Conference.

Who should attend?

Professionals involved in:

  • Drug Regulation
  • Clinical Research and Development
  • Medical and Scientific Affairs
  • Quality Assurance
  • Research and Development
  • Strategic Sourcing/Planning
  • Regulatory Affairs

Program Committee

  • Patricia  Aprea, MD
    Patricia Aprea, MD Director, Evaluation and Control of Biológicals/Research
    ANMAT, Argentina
  • Cammilla  Horta Gomes, MA, MPharm
    Cammilla Horta Gomes, MA, MPharm LATAM Regulatory Policy Lead
    Roche, Brazil
  • Maria  Guazzaroni Jacobs, PhD
    Maria Guazzaroni Jacobs, PhD Director, Quality Intelligence, Global Supply
    Pfizer Inc, United States
  • Fernanda  Lessa, MBA, MPH
    Fernanda Lessa, MBA, MPH
    N/A, Switzerland
  • Livia  Lopes
    Livia Lopes LatAm Regulatory Affairs Policy Manager
    Novartis, United States
  • Roberta  Mele Mazza, RPh, RAC
    Roberta Mele Mazza, RPh, RAC Q&RA Manager, División Diagnóstica
    Productos Roche , Argentina
  • Maria Cristina  Mota Pina, MBA
    Maria Cristina Mota Pina, MBA Director, Regulatory Policy and Intelligence -Japan, Emerging Markets, Australia
    AbbVie, Inc., United States
  • Carlos  Pinoargote
    Carlos Pinoargote Chief Operating Officer
    BRCR Global, United States
  • Ana  Padua, MSc, RPh
    Ana Padua, MSc, RPh Associate Director GRA CMC Regulatory Intelligence Biopharam Global Regulatory
    EMD Serono, Switzerland
  • Leonardo  Semprun, RPh
    Leonardo Semprun, RPh Senior Director, Global Regulatory Policy LATAM
    MSD, Panama
  • Renata De Lima Soares
    Renata De Lima Soares Regulation and Health Surveillance Specialist
    Anvisa, Brazil
  • Sonia  Viejobueno, LLM
    Sonia Viejobueno, LLM Latin America Lead, Global Regulatory Policy and Intelligence
    The Janssen Pharmaceutical Companies of Johnson & Johnson, Argentina
Load More

Contact us

Registration Questions?

Send Email

On Demand Content Preview Webinar

Registration Pathways to Accelerate Regulatory Assessment of Innovative Medicines in Latin America
Register Today!

Digital Learning Catalog

DIA Learning: eLearning Soultions